In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor
Bolten, W.W.
MMW Fortschritte der Medizin 145(5): 9
2003
ISSN/ISBN: 1438-3276 PMID: 12619199 Document Number: 557977
Document emailed within 1 workday
Related Documents
Eissele, R.; Arnold, R. 1993: Risk for developing tumors in therapy with the proton pump inhibitor omeprazole Versicherungsmedizin 45(4): 126-129Rattanasupar, A.; Sengmanee, S. 2016: Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding Journal of the Medical Association of Thailand 99(9): 988-995
Sharma, P.; Sampliner, R.E.; Camargo, E. 1997: Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus American Journal of Gastroenterology 92(4): 582-585
Chayakulkeeree, M.; Poovipirom, N.; Siengwattana, P.; Maneerattanaporn, M. 2015: Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients Journal of the Medical Association of Thailand 98(3): 232-237
Müller, P.; Simon, B.; Khalil, H.; Lühmann, R.; Leucht, U.; Schneider, A. 1992: Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients Zeitschrift für Gastroenterologie 30(11): 771-775
Konrad, G. 2012: Unsupported risks of proton pump inhibitor use American Family Physician 86(8): 723; Author Reply P723-4
Labenz, J. 2001: Ulcer therapy with a new proton pump inhibitor. one week of treatment is enough MMW Fortschritte der Medizin 143(1-2): 35-36
Kim, S.H.; Han, K.S.; Choi, W.S.; Chang, M.S.; Lee, M.G. 1997: Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1 Research Communications in Molecular Pathology and Pharmacology 98(1): 77-84
Tamura, K.; Murai, M.; Tanaka, M.; Kawano, S. 1993: Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy Nihon Rinsho. Japanese Journal of Clinical Medicine 51(12): 3261-3266
Hiraishi, H.; Shimada, T. 2010: Role of proton pump inhibitor in the management of low dose aspirin related ulcerations Nihon Rinsho. Japanese Journal of Clinical Medicine 68(11): 2096-2101
Yasuda, S.; Higashi, S.; Murakami, M.; Tomono, Y.; Kawaguchi, M. 1999: Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 37(5): 249-253
Yamagata, S. 1992: Investigation of the therapeutic use of proton pump inhibitor (PPI) by measurement of 24 hour the intra-gastric pH Nihon Rinsho. Japanese Journal of Clinical Medicine 50(1): 160-166
Depré, M.; Van Hecken, A.; Verbesselt, R.; De Lepeleire, I.; Schwartz, J.; Porras, A.; Larson, P.; Lin, C.; De Schepper, P.J. 1998: Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man International Journal of Clinical Pharmacology Research 18(2): 53-61
Traber, D.L.; Adams, T.; Sziebert, L.; Williams, P.; Traber, L.D. 1984: Failure of a protease inhibitor to affect the cardiopulmonary response to endotoxin when combined with a cyclooxygenase inhibitor Circulatory Shock 13(4): 319-323
Saitoh, T.; Otsuka, H.; Kawasaki, T.; Endo, H.; Iga, D.; Tomimatsu, M.; Fukushima, Y.; Katsube, T.; Ogawa, K.; Otsuka, K. 2009: Influences of CYP2C19 polymorphism on recurrence of reflux esophagitis during proton pump inhibitor maintenance therapy Hepato-Gastroenterology 56(91-92): 703-706
Nagaya, H.; Satoh, H.; Maki, Y. 1990: Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells Journal of Pharmacology and Experimental Therapeutics 252(3): 1289-1295
Tamura, M.; Konishi, F.; Inagami, T. 1993: A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands Journal of Cardiovascular Pharmacology 22(Suppl 2): S47-S50
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Nakamura, M.; Tahara, T.; Shiroeda, H.; Matsunaga, K.; Otsuka, T.; Yonemura, J.; Shibata, T.; Arisawa, T. 2015: The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial Hepato-Gastroenterology 62(137): 219-224
Olatunji, L.A.; Soladoye, A.O. 2010: Effects of chronic treatment with cyclooxygenase inhibitor, indomethacin on oral contraceptive-induced high blood pressure in female rats African Journal of Medicine and Medical Sciences 39(1): 21-27